These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25475634)

  • 1. A practical approach to a viral detection pipeline using existing viral and non-viral sequence resources.
    Bekkari K; Shpungin J; Thompson JR
    PDA J Pharm Sci Technol; 2014; 68(6):595-601. PubMed ID: 25475634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining a sample preparation workflow for advanced virus detection and understanding sensitivity by next-generation sequencing.
    Wang CJ; Feng SF; Duncan P
    PDA J Pharm Sci Technol; 2014; 68(6):579-88. PubMed ID: 25475632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole genome: next-generation sequencing as a virus safety test for biotechnological products.
    Cabannes E; Hébert C; Eloit M
    PDA J Pharm Sci Technol; 2014; 68(6):631-8. PubMed ID: 25475638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parallel evaluation of broad virus detection methods.
    Modrof J; Berting A; Kreil TR
    PDA J Pharm Sci Technol; 2014; 68(6):572-8. PubMed ID: 25475631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling an approach to define sensitivity of viral detection in sample matrices-examples with microarray readout.
    Feng SF; Jaing C; Thissen JB; Wang C; Duncan P
    PDA J Pharm Sci Technol; 2014; 68(6):589-94. PubMed ID: 25475633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cataloguing the taxonomic origins of sequences from a heterogeneous sample using phylogenomics: applications in adventitious agent detection.
    Charlebois RL; Ng SH; Gisonni-Lex L; Mallet L
    PDA J Pharm Sci Technol; 2014; 68(6):602-18. PubMed ID: 25475635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New technologies and challenges of novel virus detection.
    Khan AS; Ma H; Taliaferro LP; Galvin TA; Shaheduzzaman S
    PDA J Pharm Sci Technol; 2014; 68(6):661-6. PubMed ID: 25475641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of adventitious agents using next-generation sequencing.
    Richards B; Cao S; Plavsic M; Pomponio R; Davies C; Mattaliano R; Madden S; Klinger K; Palermo A
    PDA J Pharm Sci Technol; 2014; 68(6):651-60. PubMed ID: 25475640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Need for new technologies for detection of adventitious agents in vaccines and other biological products.
    Mallet L; Gisonni-Lex L
    PDA J Pharm Sci Technol; 2014; 68(6):556-62. PubMed ID: 25475629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Summary of the advanced virus detection technologies users group efforts-2013.
    Duncan P
    PDA J Pharm Sci Technol; 2014; 68(6):548-51. PubMed ID: 25475627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a549 as a new vaccine cell substrate: digging deeper with massively parallel sequencing.
    Shabram P; Kolman JL
    PDA J Pharm Sci Technol; 2014; 68(6):639-50. PubMed ID: 25475639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary Evaluation of Next-Generation Sequencing Performance Relative to qPCR and In Vitro Cell Culture Tests for Human Cytomegalovirus.
    Ng SH; Azizi A; Edamura K; Malott RJ; Charlebois RL; Logvinoff C; Schreiber M; Mallet L; Gisonni-Lex L
    PDA J Pharm Sci Technol; 2014; 68(6):563-71. PubMed ID: 25475630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adventitious Virus Detection in Cells by High-Throughput Sequencing of Newly Synthesized RNAs: Unambiguous Differentiation of Cell Infection from Carryover of Viral Nucleic Acids.
    Cheval J; Muth E; Gonzalez G; Coulpier M; Beurdeley P; Cruveiller S; Eloit M
    mSphere; 2019 Jun; 4(3):. PubMed ID: 31167947
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    MacDonald ML; Polson SW; Lee KH
    mSphere; 2021 Apr; 6(2):. PubMed ID: 33883263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of cells and biological reagents for adventitious agents using degenerate primer PCR and massively parallel sequencing.
    McClenahan SD; Uhlenhaut C; Krause PR
    Vaccine; 2014 Dec; 32(52):7115-21. PubMed ID: 25454874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of approaches to viral safety issues for biological products.
    Lubiniecki AS
    PDA J Pharm Sci Technol; 2011; 65(6):547-56. PubMed ID: 22294576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LABRADOR-A Computational Workflow for Virus Detection in High-Throughput Sequencing Data.
    Fabiańska I; Borutzki S; Richter B; Tran HQ; Neubert A; Mayer D
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Report of the 2019 NIST-FDA workshop on standards for next generation sequencing detection of viral adventitious agents in biologics and biomanufacturing.
    Cleveland MH; Anekella B; Brewer M; Chin PJ; Couch H; Delwart E; Huggett J; Jackson S; Martin J; Monpoeho S; Morrison T; Ng SHS; Ussery D; Khan AS
    Biologicals; 2020 Mar; 64():76-82. PubMed ID: 32094072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Considerations for Optimization of High-Throughput Sequencing Bioinformatics Pipelines for Virus Detection.
    Lambert C; Braxton C; Charlebois RL; Deyati A; Duncan P; La Neve F; Malicki HD; Ribrioux S; Rozelle DK; Michaels B; Sun W; Yang Z; Khan AS
    Viruses; 2018 Sep; 10(10):. PubMed ID: 30262776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Perspectives on High-Throughput Sequencing (HTS) for Adventitious Virus Detection: Upstream Sample Processing and Library Preparation.
    Ng SH; Braxton C; Eloit M; Feng SF; Fragnoud R; Mallet L; Mee ET; Sathiamoorthy S; Vandeputte O; Khan AS
    Viruses; 2018 Oct; 10(10):. PubMed ID: 30332784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.